Subsequent studies found that tumor-derived MIF increases the expansion and migration of anti-tumor Th17 cells in nasopharyngeal carcinoma through CXCR4 which ultimately was associated with a more favorable clinical outcome (172). This evidence concerns the gene CXCR4 and neoplasm.